The company’s Repatha (evolocumab) was added to optimised statin therapy in a phase 3 trial, and resulted in statistically significant regression of atherosclerosis in patients with coronary ...

Ultra-deep tech startup Nirvanic put on a fairly humble-looking robotics demo at Jeff Bezos's private MARS 2025 conference – and while the team is adamant that this implies no endorsement from ...

The top 20 biopharmas demonstrated a strong start to 2025, despite ongoing uncertainty surrounding Trump’s tariffs.

More than four years after Amgen’s cholesterol-lowering antibody Repatha was approved in the US, the company still can’t generate much sales momentum behind the product. Its latest gambit is ...

Notable contributors included Repatha (evolocumab) for hypercholesterolemia and hyperlipidemia, Blincyto (blinatumomab) for B-cell acute lymphocytic leukaemia, recently approved in June 2024 ...

18+. T&Cs apply. T&Cs Apply. Did you know that you can play the best online slots for free? That’s right, using something known as demo technology, you can spin the reels of the industry’s finest ...

Rosuvastatin is a generic prescription drug that’s used to treat high cholesterol and reduce the risk of heart disease. Rosuvastatin comes as an oral tablet and belongs to a group of drugs ...

Advancing development of next-generation precision Antibody Drug Conjugates (ADCs) to address multiple indications across a range of cancer types Continued progress of lead program, AKTX-101, for ...